Advisor Partners II’s ResMed RMD Stock Holding History

Advisor Partners II’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$581K	Sell	3,932 -4,219	-52%	-$763K	0.02%	657
2023 Q2	$1.78M	Sell	8,151 -258	-3%	-$57.5K	0.08%	244
2023 Q1	$1.84M	Buy	8,409 +242	+3%	+$52.5K	0.1%	209
2022 Q4	$1.7M	Buy	8,167 +1,409	+21%	+$310K	0.11%	213
2022 Q3	$1.48M	Buy	+6,758	New	+$1.54M	0.11%	197

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Advisor Partners II's RMD Position: Q3 2023 in Review

Advisor Partners II reduced its ResMed (RMD) stake by 52% in Q3 2023, selling an estimated $763K and leaving 3,932 shares worth $581K. The position accounts for 0.02% of the portfolio, ranked #657.

Advisor Partners II first reported a position in RMD in Q3 2022 and has held it in 5 quarters since. The position peaked at $1.84M in Q1 2023. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

Advisor Partners II held 3,932 shares of ResMed worth $581K as of Q3 2023.
Advisor Partners II sold 4,219 ResMed shares in Q3 2023, an estimated $763K.
ResMed made up 0.02% of Advisor Partners II's portfolio in Q3 2023, its #657 holding.
Advisor Partners II first reported a position in ResMed in Q3 2022 and has held it in 5 quarters since.
Advisor Partners II's ResMed position peaked at $1.84M in Q1 2023.
657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.